This week’s episode of NCQA’s Inside Health Care podcast observes National Diabetes Month. We feature a discussion with two experts in diabetes care who discuss the links between diabetes diagnosis and kidney disease. Following that, we have a chat with NCQA President Peggy O’Kane about moving Health Equity solutions to the top of U.S. health care agenda.
More than 37 million adults in the U.S. have chronic kidney disease, but because so many are asymptomatic, most of them don’t know they have it. Bayer recently teamed up with NCQA to develop a Kidney Health Toolkit, an amazing package of materials that helps providers and agencies teach the link between chronic kidney health and related conditions, including diabetes and cardiovascular disease.
Dr. Daniel Wilson, MD, is Senior Medical Director at Bayer Pharmaceuticals. Following over 25 years as a clinical cardiologist and nephrologist, Dr. Wilson served as the Medical Lead Clinician for Pfizer before joining biopharmaceutical company Relypsa as Executive Medical Director for Medical Affairs. His work led to the development of many significant medications taken by millions of people each day.